Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies

Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies

OBJECTIVE:Fatigue is a common and disabling symptom amongst people with multiple sclerosis, however it has not been compared across the central nervous system (CNS) inflammatory diseases associated with aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibodies (Ab). We explored the...

Descripció completa

Dades bibliogràfiques
Autors principals:	Yeo, T, Dos Passos, GR, Muhammed, L, Everett, R, Reeve, S, Messina, S, Probert, F, Leite, MI, Jacqueline Palace
Format:	Journal article
Idioma:	English
Publicat:	Wiley 2020

Ítems similars

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
per: Jurynczyk, M, et al.
Publicat: (2017)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
per: Jurynczyk, M, et al.
Publicat: (2017)

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
per: Maciej Jurynczyk, et al.
Publicat: (2017-12-01)

Distinguishing the brain MRI features of MS, AQP4-and MOG-antibody disease.
per: Jurynczyk, M, et al.
Publicat: (2016)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
per: Waters, P, et al.
Publicat: (2015)

RELAPSING AQP4 ANTIBODY NEGATIVE NMO WITH MOG ANTIBODIES
per: Elsone, L, et al.
Publicat: (2014)

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
per: Juryńczyk, M, et al.
Publicat: (2016)

The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis
per: Messina, S, et al.
Publicat: (2021)

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
per: Sato, D, et al.
Publicat: (2014)

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
per: Kezuka, T, et al.
Publicat: (2014)

No strong HLA association with MOG antibody disease in the UK population
per: Grant-Peters, M, et al.
Publicat: (2021)

Value of Area Postrema Syndrome in Differentiating Adults With AQP4 vs. MOG Antibodies
per: Jae-Won Hyun, et al.
Publicat: (2020-06-01)

International multicenter examination of MOG antibody assays
per: Reindl, M, et al.
Publicat: (2020)

No strong HLA association with MOG antibody disease in the UK population
per: Melissa Grant‐Peters, et al.
Publicat: (2021-07-01)

Features of the diagnosis and treatment of patients with AQP-4-positive neuromyelitis optica and MOG antibody disease
per: V. E. Avdeeva, et al.
Publicat: (2021-11-01)

Time to separate MOG-Ab-associated disease from AQP4-Ab-positive neuromyelitis optica spectrum disorder
per: Hacohen, Y, et al.
Publicat: (2018)

Disease course and disability outcomes in MOG-antibody disease in the UK
per: Jurynczyk, M, et al.
Publicat: (2017)

Prevalence of serum MOG antibody and AQP4 antibody in optic neuritis after SARS-CoV-2 infection
per: Chuan-bin Sun
Publicat: (2023-11-01)

Clinical presentation and prognosis in MOG-antibody disease: a UK study
per: Jurynczyk, M, et al.
Publicat: (2017)

A Longitudinal Comparison of the Recovery Patterns of Optic Neuritis with MOG Antibody-Seropositive and AQP4 Antibody-Seropositive or -Seronegative for Both Antibodies
per: Lin Zhou, et al.
Publicat: (2022-01-01)

Differences in Neuropathic Pain and Radiological Features Between AQP4-ON, MOG-ON, and IDON
per: Hao Kang, et al.
Publicat: (2022-05-01)

Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies
per: Elisabeth Maillart, et al.
Publicat: (2020-04-01)

Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method
per: Luca Bollo, et al.
Publicat: (2021-03-01)

Case report: Satralizumab as an adjunctive therapy for AQP-4 antibody and MOG antibody dual-negative optic neuritis in a third-trimester pregnancy case
per: Chuanbin Sun, et al.
Publicat: (2024-12-01)

Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood
per: Xuelian Chen, et al.
Publicat: (2023-03-01)

Corrigendum: Different immunological mechanisms between AQP4 antibody-positive and MOG antibody-positive optic neuritis based on RNA sequencing analysis of whole blood
per: Xuelian Chen, et al.
Publicat: (2023-08-01)

Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination
per: Bing-Yan Ren, et al.
Publicat: (2021-02-01)

Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis
per: Sotaro Mori, et al.
Publicat: (2020-01-01)

Structural and Functional Alterations in Visual Pathway After Optic Neuritis in MOG Antibody Disease: A Comparative Study With AQP4 Seropositive NMOSD
per: Chenyang Gao, et al.
Publicat: (2021-06-01)

We need to talk about MOG
per: Waters, P, et al.
Publicat: (2020)

Frequency of MOG-IgG in cerebrospinal fluid versus serum
per: Pace, S, et al.
Publicat: (2021)

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
per: Jarius, S, et al.
Publicat: (2018)

MOG antibody associated disorder (MOGAD)
per: Lilley Kate, et al.
Publicat: (2021-01-01)

Epilepsy in patients with MOG antibody disease
per: Varvara E. Avdeeva, et al.
Publicat: (2021-10-01)

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
per: Whittam, DH, et al.
Publicat: (2020)

Usefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders
per: Elena H. Martinez-Lapiscina, et al.
Publicat: (2016-09-01)

A rare case of systemic lupus erythematosus‐associated neuromyelitis optica spectrum disorder with cystic lesions and dual seropositivity for anti‐AQP4 and anti‐MOG antibodies
per: Omar Al Jassem, et al.
Publicat: (2024-09-01)

MOG-IgG1 antibodies in children
per: Waters, P, et al.
Publicat: (2018)

An international multicentre validation experiment for MOG antibodies
per: Reindl, M, et al.
Publicat: (2018)

Understanding MOG antibody-associated disease in Brazil
per: Dagoberto Callegaro, et al.
Publicat: (2023-11-01)